Price alert —
Sign in to get a one-time email the moment CRSP crosses your price. Free accounts included.
Sign in / create a free accountCRISPR Therapeutics AG is a healthcare company listed in the US.
CRSP last traded at $48.45, up 3.1% on the day; that's in the lower part of its 52-week range ($44.12–$63.45). Right now it's dipped below its recent average — a spot where watchers often look for signs the dip is stabilizing.
Earnings reports are the biggest scheduled catalysts to keep an eye on, and after the recent dip, watch whether the price stops making lower lows before assuming the worst is over.
A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.
On the latest daily bar, momentum sits mid-range (RSI 38), the trend is quiet (ADX 23), and trading is light at 0.3× normal volume. On the business side, revenue is growing 69% year over year.
Latest-bar indicator readings behind the grade — display-only, they don't move the letter.
Company fundamentals for context — display-only, they don't move the grade.
The model's verdict is “Unknown” and accounting quality screens as Adequate. Model estimates only — do your own due diligence.
- ✓ More cash than debt
- ✓ Quick ratio 16.37 (antifragile)
- ✓ Current ratio 13.32 (antifragile)
- ✓ Debt/equity 0.18 (antifragile)
- ⚠ Negative retained earnings
CRSP is a $5.0 billion company.